Xi'an International Medical Investment Company Limited (SHE:000516)
China flag China · Delayed Price · Currency is CNY
4.400
+0.020 (0.46%)
Oct 30, 2026, 3:05 PM CST

SHE:000516 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Net Income
-89.8-313.08-254.13-368.36-1,177-822.17
Depreciation & Amortization
672.15672.15730.54769.89620.31568.64
Other Amortization
333314.6113.9412.978.77
Loss (Gain) From Sale of Assets
-0.18-0.18-1.66-1.95-7.250.17
Asset Writedown & Restructuring Costs
0.250.252.590.873.361.9
Loss (Gain) From Sale of Investments
-27.98-27.98-23.77-73.8663.3365.3
Provision & Write-off of Bad Debts
-7.63-7.635.7515.556.935.93
Other Operating Activities
-175.6620.8964.67122.7181.67166.51
Change in Accounts Receivable
177.74177.74-133.05-285.53142.34-44.09
Change in Inventory
13.7813.78-2.67-9.110.63-26.63
Change in Accounts Payable
695.04695.04589.74867.72511.94486.85
Change in Other Net Operating Assets
--6.6632.8137.08135.89
Operating Cash Flow
1,3031,2761,0091,087461.34456.34
Operating Cash Flow Growth
-0.25%26.49%-7.19%135.69%1.10%1004.15%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Capital Expenditures
-206.56-262.47-547.74-762.67-1,188-1,660
Sale of Property, Plant & Equipment
34.2134.190.5-97.240.48
Divestitures
----160-
Investment in Securities
0.987.923921.3689417.66
Other Investing Activities
17.3313.242.06-20.6823.6241.98
Investing Cash Flow
-154.13-127.11-506.19-762-817.99-1,200

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Long-Term Debt Issued
-493.01717.48796.76802.791,175
Long-Term Debt Repaid
--1,593-1,372-1,061-565.18-914.98
Net Debt Issued (Repaid)
-958.64-1,100-654.68-264.22237.61259.73
Issuance of Common Stock
----32.551,201
Repurchase of Common Stock
-42.6-42.6-57.44--3.94-
Common Dividends Paid
-126.54-149.21-183.72-217.4-245.42-232.34
Other Financing Activities
35.24-16.78-2.5-83.52-75.01
Financing Cash Flow
-1,093-1,309-898.33-565.1520.81,304

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Net Cash Flow
56.52-159.43-395.4-239.82-335.85560.15

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Free Cash Flow
1,0971,014461.38324.66-726.51-1,203
Free Cash Flow Growth
11.67%119.78%42.11%---
Free Cash Flow Margin
26.36%24.89%9.58%7.03%-26.80%-41.20%
Free Cash Flow Per Share
0.490.450.200.14-0.32-0.54
Levered Free Cash Flow
403.25288.5-440.9-494.17-1,406-931.78
Unlevered Free Cash Flow
489.43374.68-332.55-357.27-1,287-812.55

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Cash Income Tax Paid
84.2272.2979.3472.34-159.63-170.39
Change in Working Capital
899.05899.05470.51608.56756.7461.29